An endless patent war for dementia patches… who will be the winner between Novartis and SK?

Published: 2014-10-14 13:31:41

Updated: 2014-10-14 13:36:59

The industry has been paying attention on a result of patent litigation for dementia patches between Novartis and SK Chemicals.

The conflict has proceeded since the late 2012 because Novartis accused SK Chemicals for infringement of patent of Exelon Patch, the company’s sticking medicine for dementia

Novartis has been working on both a patent infringement action against SK Chemicals and an ac...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.